Ambalal Sarabhai Enterprises Limited Stock Price Today (NSE: AMBALALSA)
Fundamental Score
Ambalal Sarabhai Enterprises Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Ambalal Sarabhai Enterprises Limited share price today is ₹39.82, up +3.19% on NSE/BSE as of 16 September 2026. Ambalal Sarabhai Enterprises Limited (AMBALALSA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹237.80 (Cr). The 52-week high for AMBALALSA share price is ₹49.90 and the 52-week low is ₹37.15. At a P/E ratio of 12.88x, AMBALALSA is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 12.38% and a debt-to-equity ratio of 0.36.
Ambalal Sarabhai Enterprises Limited Share Price Chart — NSE/BSE Historical Performance
Ambalal Sarabhai Enterprises Limited share price chart: -12.23% return over the past month. 52-week high ₹49.90, 52-week low ₹37.15.
Ambalal Sarabhai Enterprises Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹38.45 | ₹40.00 | ₹37.15 | ₹39.82 | 41.42K (Cr) | |
| ₹40.50 | ₹40.98 | ₹38.32 | ₹38.59 | 45.06K (Cr) | |
| ₹41.10 | ₹41.79 | ₹39.68 | ₹40.33 | 56.92K (Cr) | |
| ₹42.00 | ₹42.50 | ₹41.10 | ₹41.54 | 29.62K (Cr) | |
| ₹40.62 | ₹42.79 | ₹40.62 | ₹42.43 | 20.45K (Cr) | |
| ₹42.25 | ₹43.10 | ₹41.50 | ₹42.05 | 38.63K (Cr) | |
| ₹42.52 | ₹44.75 | ₹42.52 | ₹42.98 | 23.82K (Cr) | |
| ₹43.67 | ₹45.60 | ₹42.80 | ₹43.73 | 39.96K (Cr) | |
| ₹44.94 | ₹45.50 | ₹43.51 | ₹43.67 | 24.30K (Cr) | |
| ₹42.25 | ₹44.50 | ₹42.25 | ₹44.10 | 44.13K (Cr) |
Ambalal Sarabhai Enterprises Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹46.00 | ₹46.20 | ₹37.15 | ₹39.82 | -13.43% | |
| ₹33.01 | ₹49.90 | ₹33.01 | ₹45.62 | +38.20% | |
| ₹32.98 | ₹36.48 | ₹30.00 | ₹34.87 | +5.73% | |
| ₹34.40 | ₹38.85 | ₹31.00 | ₹32.39 | -5.84% | |
| ₹31.04 | ₹36.58 | ₹30.00 | ₹35.69 | +14.98% | |
| ₹25.13 | ₹36.00 | ₹24.05 | ₹31.80 | +26.54% | |
| ₹25.01 | ₹29.25 | ₹23.90 | ₹24.27 | -2.96% | |
| ₹28.89 | ₹29.85 | ₹25.06 | ₹26.24 | -9.17% | |
| ₹28.59 | ₹29.44 | ₹23.12 | ₹27.58 | -3.53% | |
| ₹28.42 | ₹33.00 | ₹25.97 | ₹28.58 | +0.56% | |
| ₹33.40 | ₹33.40 | ₹28.26 | ₹28.40 | -14.97% | |
| ₹32.64 | ₹38.50 | ₹31.50 | ₹32.55 | -0.28% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Ambalal Sarabhai Enterprises Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Ambalal Sarabhai Enterprises Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMBALALSA across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Attractive Valuation (P/E: 12.88 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Interest Coverage (5.33x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Limited Growth History (4.35% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Liquidity Concerns (Current Ratio: 0.98)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Negative Free Cash Flow (₹-4.76 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Ambalal Sarabhai Enterprises Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Ambalal Sarabhai Enterprises Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Ambalal Sarabhai Enterprises LimitedAmbalal Sarabha...Selected✓ AMBALALSA • 500009 | 29.1/100 | ₹39.82₹40 | ₹237.80₹237.80 | 12.88Average 12.9 Average | 12.38%Average 12.38% Average | 11.69%Average 11.69% Average | 0.36Excellent 0.4 Excellent | 9.51%Good 9.51% Good | 4.35%Average 4.35% Average | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1864.90₹1865 | ₹447445.46₹447445.46 | 37.00Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9488.00₹9488 | ₹251432.00₹251432.00 | 86.09Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4930.00₹4930 | ₹166860.78₹166860.78 | 78.75Average 78.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1127.40₹1127 | ₹112514.52₹112514.52 | 25.13Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1363.10₹1363 | ₹110118.03₹110118.03 | 32.66Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1937.00₹1937 | ₹104646.43₹104646.43 | 95.61Average 95.6 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1698.90₹1699 | ₹97754.71₹97754.71 | 26.55Average 26.5 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.00₹2100 | ₹96022.50₹96022.50 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.00₹1145 | ₹95607.50₹95607.50 | 29.59Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2265.00₹2265 | ₹93544.50₹93544.50 | 45.77Average 45.8 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447445.46 Cr
- Divi's Laboratories Limited share price251432.00 Cr
- Torrent Pharmaceuticals Limited share price166860.78 Cr
- Zydus Lifesciences Limited share price112514.52 Cr
- Cipla Limited share price110118.03 Cr
Ambalal Sarabhai Enterprises Limited PE Ratio History
Historical price-to-earnings ratio for AMBALALSA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.74 | ₹53.58 | 72.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Ambalal Sarabhai Enterprises Limited Quarterly Performance
Latest quarterly metrics for AMBALALSA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
1.05%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
13.44%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
4.35%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
9.51%
Compounded annual net profit growth over 5 years
Ambalal Sarabhai Enterprises Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMBALALSA — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Ambalal Sarabhai Enterprises Limited Financial Statements
Annual income statement, balance sheet and cash flow for Ambalal Sarabhai Enterprises Limited (AMBALALSA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Ambalal Sarabhai Enterprises Limited
About AMBALALSA (Ambalal Sarabhai Enterprises Limited)
Ambalal Sarabhai Enterprises Ltd is a pioneer in the Indian pharmaceutical landscape, forging a legacy of innovation and commitment to healthcare solutions. Rooted in a rich histor...y, the company has evolved into a multifaceted organization dedicated to developing, producing, and distributing a diverse portfolio of pharmaceutical products. From addressing critical therapeutic areas like oncology and infertility to providing essential generic medications and animal health solutions, AMBALALSA strives to meet the evolving needs of patients and healthcare professionals. The company's emphasis on research and development ensures a steady pipeline of novel formulations and therapeutic advancements, solidifying its position as a trusted partner in promoting health and well-being. Driven by a pursuit of scientific excellence, AMBALALSA boasts state-of-the-art manufacturing facilities adhering to stringent global quality standards. This dedication to quality permeates every aspect of its operations, from sourcing raw materials to rigorous testing and packaging processes. The company's product range spans a wide spectrum, including specialized treatments for uro-gynaecological conditions, vital antifungal active ingredients, and vitamin C formulations. In addition to pharmaceuticals, AMBALALSA also offers analytical instruments and measuring tools, catering to the needs of research institutions and quality control laboratories. This holistic approach positions AMBALALSA as a comprehensive solution provider in the healthcare ecosystem. Beyond its core pharmaceutical offerings, AMBALALSA demonstrates a commitment to global reach, actively exporting its products to international markets. This strategic expansion reflects the company's ambition to improve access to quality healthcare worldwide. AMBALALSA also supports the pharmaceutical industry by supplying finished dosage forms and active pharmaceutical ingredients to other manufacturers. As it navigates the complexities of the modern healthcare landscape, AMBALALSA remains steadfast in its mission to enhance patient outcomes through innovative products, uncompromising quality, and a dedication to ethical practices, thereby solidifying its position as a significant contributor to the advancement of pharmaceutical science and patient care.
Company Details
Key Leadership
AMBALALSA Share Price: Frequently Asked Questions
What is the current share price of Ambalal Sarabhai Enterprises Limited?
Ambalal Sarabhai Enterprises Limited (AMBALALSA) trades at ₹39.82 on NSE and BSE. Market cap ₹237.80 (Cr). Educational data only.
What is the P/E ratio of Ambalal Sarabhai Enterprises Limited?
Ambalal Sarabhai Enterprises Limited has a P/E of 12.88x vs industry average 34.89x.
What is the Bull Run score for Ambalal Sarabhai Enterprises Limited?
Ambalal Sarabhai Enterprises Limited has a Bull Run score of 29.1/100 based on 25+ financial parameters.
Does Ambalal Sarabhai Enterprises Limited pay dividends?
Ambalal Sarabhai Enterprises Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Ambalal Sarabhai Enterprises Limited?
Ambalal Sarabhai Enterprises Limited has ROE of 12.38%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Ambalal Sarabhai Enterprises Limited?
Ambalal Sarabhai Enterprises Limited has debt-to-equity of 0.36.
Is Ambalal Sarabhai Enterprises Limited a good investment?
Bull Run gives Ambalal Sarabhai Enterprises Limited a score of 29.1/100. This is not investment advice — consult a SEBI-registered advisor.